Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1Breast 1

Conditions

Breast Neoplasms 119Triple Negative Breast Neoplasms 8Inflammatory Breast Neoplasms 8Colorectal Neoplasms 8Ovarian Neoplasms 6Neoplasms 6Stomach Neoplasms 5Neoplasm Metastasis 5Carcinoma, Non-Small-Cell Lung 4Breast Neoplasms, Male 4Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Prostatic Neoplasms 3Pancreatic Neoplasms 3Lung Neoplasms 3Head and Neck Neoplasms 3Esophageal Neoplasms 3Carcinoma, Renal Cell 3Multiple Myeloma 2Melanoma 2Hematologic Neoplasms 2Fallopian Tube Neoplasms 2Endometrial Neoplasms 2Colonic Neoplasms 2Women With Primary Breast Cancer 1Tracheal Neoplasms 1Thyroid Neoplasms 1Thrombocytosis 1Solitary Pulmonary Nodule 1

Interventions

Psychiatric Rehabilitation 1Neoadjuvant Therapy 1Mammaplasty 1Hyperbaric Oxygenation 1Fluorouracil 1Fibrin Tissue Adhesive 1Epirubicin 1Docetaxel 1Dexamethasone 1Cyclophosphamide 1Blood Specimen Collection 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Postoperative Complications × Fluorouracil × Breast × Clear all
NCT01093235 2010-03-25

Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Nonmetastatic Breast Cancer

National Cancer Institute (NCI)

Phase 3 Unknown
800 enrolled
Breast

Breast Neoplasms, Postoperative Complications, Breast Neoplasms, Male, Inflammatory Breast Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡